JPMorgan Chase & Co’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
652,199
-1,592,233
-71% -$27.2M ﹤0.01% 2135
2025
Q1
$143M Buy
2,244,432
+223,828
+11% +$14.3M 0.01% 731
2024
Q4
$246M Sell
2,020,604
-178,279
-8% -$21.7M 0.02% 551
2024
Q3
$275M Buy
2,198,883
+355,114
+19% +$44.4M 0.02% 544
2024
Q2
$291M Buy
1,843,769
+15,167
+0.8% +$2.4M 0.02% 478
2024
Q1
$237M Buy
1,828,602
+526,045
+40% +$68.1M 0.02% 567
2023
Q4
$126M Sell
1,302,557
-3,305,758
-72% -$319M 0.01% 729
2023
Q3
$559M Buy
4,608,315
+204,222
+5% +$24.8M 0.06% 268
2023
Q2
$504M Buy
4,404,093
+701,149
+19% +$80.3M 0.05% 299
2023
Q1
$510M Buy
3,702,944
+2,459,497
+198% +$339M 0.06% 290
2022
Q4
$161M Buy
1,243,447
+522,434
+72% +$67.7M 0.02% 553
2022
Q3
$79.7M Sell
721,013
-302,735
-30% -$33.5M 0.01% 761
2022
Q2
$76.7M Sell
1,023,748
-66,918
-6% -$5.02M 0.01% 803
2022
Q1
$85.2M Buy
1,090,666
+42,043
+4% +$3.28M 0.01% 842
2021
Q4
$94.4M Sell
1,048,623
-464,780
-31% -$41.9M 0.01% 841
2021
Q3
$140M Buy
1,513,403
+207,061
+16% +$19.1M 0.02% 669
2021
Q2
$102M Buy
1,306,342
+552,744
+73% +$43M 0.01% 834
2021
Q1
$56.2M Sell
753,598
-1,001
-0.1% -$74.6K 0.01% 1028
2020
Q4
$129M Sell
754,599
-371,910
-33% -$63.4M 0.02% 640
2020
Q3
$159M Sell
1,126,509
-451,404
-29% -$63.8M 0.03% 507
2020
Q2
$253M Buy
1,577,913
+433,450
+38% +$69.5M 0.05% 354
2020
Q1
$112M Buy
1,144,463
+207,113
+22% +$20.3M 0.03% 506
2019
Q4
$121M Buy
937,350
+833,885
+806% +$108M 0.02% 560
2019
Q3
$7.8M Buy
103,465
+5,605
+6% +$422K ﹤0.01% 1944
2019
Q2
$12.7M Sell
97,860
-116,586
-54% -$15.1M ﹤0.01% 1592
2019
Q1
$25.6M Buy
214,446
+9,146
+4% +$1.09M 0.01% 1206
2018
Q4
$22.4M Buy
205,300
+119,377
+139% +$13M 0.01% 1197
2018
Q3
$13.9M Sell
85,923
-115,038
-57% -$18.6M ﹤0.01% 1639
2018
Q2
$26.6M Sell
200,961
-508,109
-72% -$67.2M 0.01% 1221
2018
Q1
$52.5M Buy
709,070
+273,841
+63% +$20.3M 0.01% 834
2017
Q4
$24.2M Buy
435,229
+117,429
+37% +$6.53M 0.01% 1271
2017
Q3
$15M Buy
317,800
+41,975
+15% +$1.98M ﹤0.01% 1497
2017
Q2
$9.3M Buy
275,825
+114,300
+71% +$3.85M ﹤0.01% 1754
2017
Q1
$4.78M Buy
161,525
+98,025
+154% +$2.9M ﹤0.01% 2120
2016
Q4
$1.74M Sell
63,500
-5,000
-7% -$137K ﹤0.01% 2746
2016
Q3
$4.21M Buy
68,500
+67,930
+11,918% +$4.17M ﹤0.01% 2111
2016
Q2
$11K Sell
570
-4,364
-88% -$84.2K ﹤0.01% 3813
2016
Q1
$96K Buy
4,934
+385
+8% +$7.49K ﹤0.01% 3286
2015
Q4
$176K Buy
+4,549
New +$176K ﹤0.01% 3152
2015
Q1
Hold
0
3513
2014
Q4
Hold
0
3487
2013
Q4
Sell
-16,973
Closed -$801K 3752
2013
Q3
$801K Sell
16,973
-8,927
-34% -$421K ﹤0.01% 3109
2013
Q2
$986K Buy
+25,900
New +$986K ﹤0.01% 2930